Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

Presenter: Ryo Hikida

October 29, 2024

Presentation TCT 2024

TCT 699: Mortality Risk in Patients Undergoing Endovascular Therapy for Lower Extremity: Artery Disease and Taking a Renin-Angiotensin-Aldosterone System Inhibitor: MIKENEKO Multi-Center Study

Presenter: Kazuki Tobita

October 29, 2024

Presentation TCT 2024

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

TCT 812: The “Codi IAM Score” Predicts Low Complications Risk in Patients After Primary PCI

Presenter: Omar Abdul Jawad Altisent

October 28, 2024

Presentation TCT 2024

Lipid-Lowering Therapies for High-Risk Patients: Act Early and Target Aggressively

Presenter: Marc Bonaca

October 28, 2024

Presentation TCT 2024

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

Presenter: John Connolly

October 28, 2024

Presentation TCT 2024

Mechanical Circulatory Support of High-Risk PCI With a Novel, Low-Profile pMCS: First Results of the Impella ECP Pivotal Study

Presenter: Amir Kaki

October 27, 2024

Presentation TCT 2024

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

October 27, 2024

Presentation TCT 2024

TCT 762: Long-Term Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Low and Intermediate Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Presenter: Abdul Mueez Alam Kayani

October 27, 2024

Presentation TCT 2024

TCT 761: Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Systematic Review and Meta-Analysis

Presenter: Prakash Upreti

October 27, 2024

Presentation TCT 2024

TCT 146: Impact of Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

Presenter: Kazuki Suruga

October 27, 2024

Presentation NY Valves 2024

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

Health Related Quality of Life and Functional Status Outcomes Comparing Transcatheter and Surgical Aortic Valve Replacement in Low-Intermediate Risk Patients for Surgery: A Metanalysis of Randomized Control Trials

Presenter: Errol Christopher Moras

June 06, 2024

Presentation NY Valves 2024

Predictors of Mortality Following Transcatheter Aortic Valve Replacement in Patients With Classical Low-Flow Low-Gradient Severe Aortic Stenosis

Presenter: Besir Besir

June 06, 2024

Presentation NY Valves 2024

The Costs of Low-Risk TAVR Implant and All-Cause, Long-Term Follow Up Care in the Medicare Fee-For-Service Population

Presenter: Kael Wherry

June 06, 2024

Presentation NY Valves 2024

Outcomes of Patients With Low-Flow Low-Gradient and Normal-Flow Low-Gradient Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Presenter: Besir Besir

June 06, 2024

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation ACC 2024

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Presenter: Eric Quinton Klug

April 07, 2024

Presentation

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

February 28, 2024

Advertisement

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

TCT 699: Mortality Risk in Patients Undergoing Endovascular Therapy for Lower Extremity: Artery Disease and Taking a Renin-Angiotensin-Aldosterone System Inhibitor: MIKENEKO Multi-Center Study

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

TCT 812: The “Codi IAM Score” Predicts Low Complications Risk in Patients After Primary PCI

Lipid-Lowering Therapies for High-Risk Patients: Act Early and Target Aggressively

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

Mechanical Circulatory Support of High-Risk PCI With a Novel, Low-Profile pMCS: First Results of the Impella ECP Pivotal Study

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

TCT 762: Long-Term Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Low and Intermediate Risk Patients: A Meta-Analysis of Randomized Controlled Trials

TCT 761: Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Systematic Review and Meta-Analysis

TCT 146: Impact of Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

Health Related Quality of Life and Functional Status Outcomes Comparing Transcatheter and Surgical Aortic Valve Replacement in Low-Intermediate Risk Patients for Surgery: A Metanalysis of Randomized Control Trials

Predictors of Mortality Following Transcatheter Aortic Valve Replacement in Patients With Classical Low-Flow Low-Gradient Severe Aortic Stenosis

The Costs of Low-Risk TAVR Implant and All-Cause, Long-Term Follow Up Care in the Medicare Fee-For-Service Population

Outcomes of Patients With Low-Flow Low-Gradient and Normal-Flow Low-Gradient Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content